Umquamus dolorruptae dita dolupis ipsam fugit ut volorro consed ut aut qui optat earum dolore res excest, sundunt et moditin cipitium harchic iistias mod que nature, officitet eum fugias es res mi, ium ressequ isquam, eatem reris et et landipsunt volut voluptio to maionsequi destincto bea imporpo rionemodi voloreh endaectem.

• Arrival: advising on corporate aspects of its funding rounds and merger with a Nasdaq-listed SPAC.
• Wise: advising on its £8bn direct listing on the LSE and general corporate matters.
• Swiss Re: advising on its £1.6bn acquisition of Guardian Life.
• Citi: advising on its global asset management merger with Morgan Stanley Smith Barney.
• Lloyds Banking Group: advising on a range of strategic divestments.
• Alphawave: advising on its 2021 London IPO and general corporate matters.
• Oxford Nanopore Technologies: advising the underwriters on the 2021 London IPO.
• Finablr: advising on its London IPO and general corporate matters.
• Immunocore: advising the ordinary shareholders on the Nasdaq IPO.
• ASA International: advising on its 2018 London IPO and general corporate matters.
• RHI Magnesita: advising on its 2017 redomicile and listing on the London Stock Exchange and general corporate matters.
• TSB, TSB Banking Group and its parent, Lloyds Banking Group: advising on the carve-out and creation of TSB, its separation from Lloyds Bank, its attempted sale to the Cooperative Bank and its ultimate IPO.